This promising small-cap growth company could crack America!

A strong record of success, a positive outlook and oodles of growth potential make this one to watch closely, in my view.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

You need to look no further for a dream small-cap investment than Tristel (LSE: TSTL). The firm manufactures infection prevention and contamination control products using chlorine dioxide chemistry and business has been growing nicely.

Revenue is up around 142% over the past five years and normalised earnings have shot the lights out, rising more than 2,000%. There’s been robust cash inflow over the period, which has given solid support to profits and enabled a rise in the dividend of about 1,225%. The figures prove the firm’s growth has been worthwhile and profitable, and investors have been rewarded with a rise in the share price of about 1,400%. Could we really ask any more of a small-cap investment?

More great results

There’s more good news in today’s half-year results report. Revenue is up 12% compared to the equivalent period last year and much of the advance reflects progress abroad. Overseas sales increased by 19% and now make up 53% of total sales. Earnings per share lifted 13% and the directors expressed confidence in the outlook by raising the interim dividend by a whopping 28%.

In November, Tristel acquired the Ecomed Group, which it is integrating into operations now. We’ll get a better idea of how the new addition is contributing to profits with the full-year report in around six-months’ time.

Other highlights include receiving a couple of US Environmental Protection Agency (EPA) approvals, which are part of a long-running effort to get all the regulatory approvals in place before attempting to break into the US market. And, interestingly, the company transferred the responsibility for CE marking of its medical device products from BSI UK to BSI Amsterdam “to mitigate Brexit-related risks,” and also set up a warehouse hub in Antwerp. But the firm seems to have some confidence in the looming post-Brexit environment because it also leased a new warehouse in Newmarket.

Brexit-ready and poised to grow

Chief executive Paul Swinney said in the report the company had executed the best plan it can to “mitigate the potential effects of a no-deal Brexit.”  Indeed, he owned up to looking forward with “a high degree of confidence.” And City analysts following the firm seem optimistic too, predicting double-digit percentage advances in earnings for the full year and the following year to June 2020.

I’m bullish on the firm too. I think the company has decent financial quality indicators with the return-on-capital figure running close to 21% and operating margin at almost 18%. The management seems to be well-motivated and executing well. If all the ongoing regulatory hurdles can be negotiated without breaking the firm’s bank account and within a reasonable time frame, we could see another explosion in growth if Tristel can crack the US market.

But the valuation looks full, which reflects all the operational success so far. At today’s share price close to 290p, the forward-looking price-to-earnings (P/E) ratio is sitting around 24 for the trading year to June 2020. Meanwhile, the share-price chart shows consolidation since August 2017. I’m not against high-looking P/E ratios as long as a company keeps on delivering decent growth, and I think the US opportunity looks exciting with Tristel. 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Kevin Godbold has no position in any share mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

My ISA is ready for a 30% penny stock crash on 30 October!

Investors in AIM-listed small-cap and penny stocks could be in for a fright later this month when the budget is…

Read more »

Road trip. Father and son travelling together by car
Investing Articles

Where will the Tesla share price go next? Here’s what the experts say

The Tesla share price has been going pretty much sideways since 2021, and its robotaxi event hasn't had much of…

Read more »

British Pennies on a Pound Note
Investing Articles

Can this 8%+ yielding penny share maintain its dividend?

Our writer holds this penny share and likes its yield of over 8%. But recent business performance has made him…

Read more »

Dividend Shares

How I could make a 10% yield via dividend shares for a juicy second income

Jon Smith explains how he could build a diversified portfolio of stocks with an exceptionally high yield for his second…

Read more »

Passive and Active: text from letters of the wooden alphabet on a green chalk board
Top Stocks

5 top ETFs Fools own in their Stocks and Shares ISAs

Do you own any ETFs in your Stocks and Shares ISA? Here, five Fools reveal why they have positions in…

Read more »

The flag of the United States of America flying in front of the Capitol building
Investing Articles

Is it madness to buy the S&P 500 now?

The S&P 500 has been on a tear for many years. But a (very) frothy valuation leaves our Foolish writer…

Read more »

Two white male workmen working on site at an oil rig
Investing Articles

The Shell share price could rocket past 3,000p, analysts claim, if oil heads for $300

In today's uncertain times the Shell share price could go anywhere, in any direction, says Harvey Jones. But he still…

Read more »

Investing Articles

What’s going on with the easyJet share price?

Harvey Jones is impressed by the strong recovery in the easyJet share price over the last couple of years. Now…

Read more »